ST. PAUL, Minn.--(BUSINESS WIRE)--Synovis Life Technologies, Inc. (Nasdaq: SYNO), announced today that it has closed on the previously announced sale of substantially all of the assets of its interventional business to Heraeus Vadnais, located in Vadnais Heights, Minn., and related entities. “With the completion of this transaction, we can focus our attention and resources on opportunities in the soft tissue repair and other surgical markets,” said Richard W. Kramp, Synovis Life Technologies president and chief executive officer. “We believe there is great potential for biomaterial products based on our Veritas® technology platform and are excited by the array of applications in soft tissue repair and regeneration. Further, we have a direct sales force in place to bring our products – whether developed by Synovis or acquired – to the surgeons who implant them.”
